Description
Saltica (Renacap) 50/250 mg is a combination inhalation capsule containing Salmeterol (50 mcg), a long-acting bronchodilator, and Fluticasone Propionate (250 mcg), an inhaled corticosteroid. It is designed for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in patients who require both long-term bronchodilation and anti-inflammatory therapy. Salmeterol works by relaxing the muscles in the airways, making breathing easier, while Fluticasone reduces inflammation and swelling in the lungs. Together, they help to prevent symptoms such as wheezing, coughing, chest tightness, and shortness of breath. Saltica is not suitable for acute asthma attacks but is effective for long-term control when used regularly. It is typically administered twice daily using a dry powder inhalation device. After use, patients are advised to rinse their mouths to reduce the risk of oral infections like thrush. Regular monitoring and adherence to prescribed doses are essential to achieve the best outcomes with this medication.
.jpg)
.webp)
 50500 mg.jpeg)
.webp)
.webp)
.webp)
.webp)
.jpeg)
.webp)
.webp)
.jpg)
.webp)
.webp)
Change Language